deltatrials
Unknown PHASE2 INTERVENTIONAL 3-arm NCT05138887

A Study for Assessing the Efficacy and Safety of BH4 in Radiation Enteritis

Clinical Professor

Sponsor: West China Second University Hospital

Interventions Tetrahydrobiopterin
Updated 5 times since 2022 Last updated: Feb 25, 2022 Started: Mar 1, 2022 Primary completion: Oct 1, 2023 Completion: Mar 1, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Radiation Enteritis, this trial is ongoing. The trial is conducted by West China Second University Hospital and has accumulated 5 data snapshots since 2022. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2022 – ~Apr 2022 · 3 months · monthly snapshot~Apr 2022 – ~Apr 2024 · 24 months · monthly snapshotRecruiting~Apr 2024 – ~Jul 2024 · 3 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 21 months · monthly snapshotUnknown

Change History

5 versions recorded
  1. Sep 2024 — Present [monthly]

    Unknown PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE2

    Status: Unknown StatusUnknown

  3. Apr 2024 — Jul 2024 [monthly]

    Unknown Status PHASE2

    Status: RecruitingUnknown Status

  4. Apr 2022 — Apr 2024 [monthly]

    Recruiting PHASE2

    Status: Not Yet RecruitingRecruiting

  5. Jan 2022 — Apr 2022 [monthly]

    Not Yet Recruiting PHASE2

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • West China Second University Hospital
Data source: West China Second University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations